Therapeutic cancer vaccine

Details for Australian Patent Application No. 2004228106 (hide)

Owner Survac ApS

Inventors Andersen, Mads Hald; Straten, Per Thor

Agent Peter Maxwell & Associates

Pub. Number AU-B-2004228106

PCT Pub. Number WO2004/089980

Priority PA 2003 00572 11.04.03 DK; 60/461,803 11.04.03 US

Filing date 7 April 2004

Wipo publication date 21 October 2004

Acceptance publication date 13 May 2010

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

1 December 2005 PCT application entered the National Phase

  PCT publication WO2004/089980 Priority application(s): WO2004/089980

5 January 2006 Assignment before Grant

  Kraeftens Bekaempelse The application has been assigned to Survac ApS

13 May 2010 Application Accepted

  Published as AU-B-2004228106

9 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004228108-Polyolefin tube

2004228090-Container shut-off valve with venting